Celebrex, NSAID Labeling Must Include Skin Reactions Warning, FDA Says

FDA is requiring labeling for non-steroidal anti-inflammatory drugs include a warning on skin reactions, in addition to a boxed warning on cardiovascular and gastrointestinal risk